Post by Sanofi

In the latest episode of our Partner Spotlight series, Alyssa Johnsen, M.D., Ph.D., Senior Vice President, Global Therapeutic Area Head of Immunology and Inflammation Development at Sanofi , sits down with Nenad Tomasevic, Founder and CEO of Dren Bio, to discuss how strategic partnerships are helping advance the next generation of treatments for immune mediated diseases. The most impactful collaborations are built on openness, scientific rigor and the agility to let the science lead. By bringing together complementary expertise and a shared commitment to innovation, partnerships can help accelerate promising science with the goal of delivering new therapies for patients. Watch the full conversation to learn more about how Sanofi and Dren Bio are working together to help shape the future of immunology: http://spkl.io/60477Jkwd

Video Content